Different suppressor genes and oncogenes have been found among different histopathological subgroups of patients (i.e., the PTEN mutation associated with endometrioid endometrial carcinoma and the p53 mutation in serous endometrial carcinoma [63]). The gene discussed is TP53; the disease is endometrial endometrioid carcinoma.